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A lysine derivative, 3-[Na[Ne-[2*,4*-dinitrophenyl]-ami-
no-n-hexanoyl-L-lysylamido]-propane-1-ol, a novel
amine substrate of transglutaminases, was synthesized
and delivered into intact HL-60 and U937 human leuke-
mia cells to probe the function of the intracellular en-
zyme. The novel substrate compound was covalently in-
corporated into intracellular proteins in these cells
expressing high levels of tissue transglutaminase and
undergoing apoptosis following the induction of their
differentiation with dimethyl sulfoxide and retinoic
acid. Immunoaffinity purification and microsequencing
of labeled proteins identified cytoplasmic actin as the
main endogenous glutaminyl substrate in these cells. As
shown by confocal image analysis, cells revealed dis-
tinct labeling of the microfilament meshwork structures
by the novel compound as the result of the intracellular
action of transglutaminase.
Transglutaminases (TGases)1 are Ca21-dependent enzymes
catalyzing an acyl transfer reaction in which new g-amide
bonds are formed between a g-carboxamide group of peptide-
bound glutamine residues and various primary amines (1, 2).
Under physiological conditions the amine substrates are either
naturally occurring polyamines or e-amino groups of peptide-
bound lysyl residues. In the latter case the reaction results in
the formation of g-glutamyl-e-aminolysine cross-links between
proteins. The number of reactive glutaminyl substrates is
highly restricted, whereas the specificity for amine substrates
is modest (3, 4), although peptide-bound lysyl residues are
better substrates than other diamine derivatives (1). Several
members of the TGase family have been identified (2), and the
specificity using different glutaminyl substrates varies depend-
ing on the type of transglutaminase.
The ubiquitous tissue transglutaminase is a monomeric glob-
ular protein, which has been implicated in a wide variety of
functions resulting in intra- and/or extracellular structural
alterations (2). These include modeling of the extracellular
matrix (5), stimulus-secretion coupling (6), receptor-mediated
endocytosis (7), cell differentiation (8), tumor growth (9), and
programmed cell death (10–12). However, specific modification
of defined intracellular substrate proteins by tissue transglu-
taminase has not yet been linked to the suspected intracellular
functions mainly because of the difficulties in specific labeling
of such proteins without compromising cellular integrity. At-
tempts have been made in the past to distinguish putative and
real intracellular substrates of TGases (13–15); these trials,
however, were restricted by the poor cellular uptake of the
amines used. The approach presented here is based on a novel
derivative of L-lysine linked with a dinitrophenol haptenic
group through the a-amino group of an aminohexanoic acid
spacer and bearing a hydrophilic head on its a-carboxyl group.
It was found that this compound was utilized by intracellular
TGase for modification of its glutaminyl substrates without any
obvious violation of cellular integrity.
Several lines of evidence, including isolation of highly po-
lymerized protein products from apoptotic cells (12, 16) and
immunohistological studies (17, 18), have established tissue
TGase as a useful biochemical marker of programmed cell
death without elucidating what its exact role in the death
process is. It is still debated whether the enzyme is involved in
execution of the death program as part of the killing mecha-
nism or whether, alternatively, it modulates the course of ap-
optosis by temporary stabilization of dying cells (19). Although
the complexity of biochemical processes during programmed
cell death can only be clarified by investigating living tissue,
carefully chosen in vitro cell systems can also deliver relevant
contributions to our understanding of the function of tissue
TGase in the course of apoptosis. Leukemia-derived human cell
lines, such as the promyelocytic HL-60 and the histiocytic
U937, can be induced to differentiate along the granulocytic or
monocytic pathways by several natural and synthetic inducers,
and the differentiated cells undergo apoptosis. Me2SO and
retinoic acid induce HL-60 to differentiate mostly to promyelo-
cytes (20, 21), whereas U937 cells are maturated to monocyte/
macrophage-like phenotypes. Both type of cells express high
levels of transglutaminase when undergo apoptosis following
differentiation (22–24). The maturated, macrophage-like phe-
notypes adhere to glass and contain much more nonspecific
esterase activity as compared with granulocytic forms (25, 26).
We examined the glutaminyl substrate proteins of tissue
TGase in apoptotic cell cultures by analyzing the incorporation
of the novel haptenized derivative of lysine into proteins. We
show that cytoplasmic actin serves as a main substrate for
cross-linking and that the incorporation of the label is struc-
turally associated with the actin cytoskeleton.
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Synthesis of DALP and DALP-Methyl Carbamate—All applied re-
agents were obtained from Sigma, unless otherwise indicated. Plati-
nated charcoal and dimethylformamide was obtained from Fluka AG,
Buchs, Switzerland. Applied solvents were of analytical grade and were
from Reanal Rt., Budapest, Hungary. The synthesis was started by the
conversion of 5 g of Na-carbobenzoxy-Ne-(tertiary-) butyloxycarbonyl-L-
lysine-p-nitrophenyl ester to 3-[Na-carbobenzoxy-Ne-(tertiary)-bu-
tyloxycarbonyl-L-lysylamido]-propane-1-ol by dissolving it in 20 ml of
dimethylformamide, then adding 1 ml of 3-amino-1-propanol and stir-
ring overnight at room temperature. Solvent was removed in vacuum,
and residue was taken up in ChCl3. This solution was washed with 0.01
M HCl, water, and 0.1 M Na2CO3, then crystallized from petroleum
ether. The previous product (2.7 g) was dissolved in 15 ml of methanol
containing 4.4% formic acid and stirred with 0.15 g of platinated char-
coal for 4 h at room temperature. Catalyst was filtered, and the solution
was concentrated in vacuum, taken up in 50% methanol, and passed
through a 1 3 5-cm Dowex 1 column in OH form. The resulting amor-
phous material (3-{Ne-(tertiary)-butyloxycarbonyl-L-lysylamido]-pro-
pane-1-ol, 1.8 g) was dissolved in 12 ml of dimethylformamide, dried
over P2O5, and coupled with 3 g of N-2,4-dinitrophenyl-e-amino-n-ca-
proic acid by adding 0.7 g of 1-hydroxybenzotriazole and 1.1 g of dicy-
clohexylcarbodiimide to the solution and stirring overnight at room
temperature. After addition of 1 ml of water, the dicyclohexylurea was
filtered off and the mixture was concentrated in vacuum, taken up in
ethyl acetate, and washed as above. After removal of the solvent in
vacuum, the residue was treated with 100% trifluoroacetic acid for 30
min on ice. Excess acid was evaporated in vacuum, and the final product
was purified on an Isco preparative C18 HPLC column (Isco Inc.,
Lincoln, NE) using an isocratic mobile phase of 25% acetonitrile and
0.1% trifluoroacetic acid. The final yield was 1.55 g of 3-[Na-[Ne-[29,49-
dinitrophenyl]-amino-n-hexanoyl]-L-lysylamido]-propane-1-ol (DALP,
structure shown in Fig. 1) in trifluoroacetic acid salt form (26% of
theoretical). The structure of the final product was verified by proton
and 13C NMR as well as by mass spectroscopy. The methyl carbamate
form of DALP was always prepared freshly by adding 5 ml of methyl
chloroformate (Aldrich) to 25 mg of DALP dissolved in 0.25 ml of
triethylamine (100 mM) and by subsequent lyophilization.
Verification of Transglutaminase Substrate Properties of DALP—
Dimethylated casein was incubated with DALP in the presence of
partially purified guinea pig liver tissue transglutaminase (Sigma) and
Ca21 for 60 min, after which unbound DALP was removed by gel
filtration. Protein was exhaustively digested by proteases (27) and
analyzed by reverse phase HPLC chromatography on a NovaPack 3.9 3
150-mm C18 column (Waters, Division of Millipore, Milford, MA) by
using a 1 ml/min isocratic elution with 25% acetonitrile in 0.14 M
sodium acetate, pH 6.35. Absorbance was detected at 365 nm. The
distinct peak eluted at 22 min was identified as g-glutamyl-DALP by its
digestibility with g-glutamyl-amine cyclotransferase (prepared from
rabbit kidney according to Fink and Folk; Ref. 28), which resulted in the
release of DALP (eluted at 33 min under the same conditions). The
same approach was used to prove that the incorporation of DALP into
proteins of intact cells was TGase-dependent; in this case the labeled
proteins were eluted from SDS-polyacrylamide gel and exhaustively
digested by proteases, and then the digest was analyzed by HPLC. A Km
of 3 mM was determined for the incorporation of DALP into dimethyl-
casein at 37 °C and pH 8.5 by using a plated enzyme-linked immunosor-
bent assay (29) in which the originally used 5-(biotinamido)pen-
tylamine was replaced by varying concentrations of DALP. The DALP-
methyl carbamate did not exert significant inhibitory properties on this
reaction at its maximal solubility concentration in water (32 mM at
37 °C).
Induction of Differentiation and Labeling of Cells—Mycoplasma free
HL60 and U937 cell lines (ECACC, Wilts, United Kingdom (UK)) were
grown in RPMI 1640 medium containing 10% fetal bovine serum and
penicillin/streptomycin at 37 °C with air/CO2 (19:1). Both cell lines were
seeded at 5 3 105 cells/ml in RPMI 1640 with 10% fetal bovine serum,
1.25% Me2SO (Hybrimax quality, Sigma), 1 mM all-trans-RA, and 25 mM
DALP-methyl carbamate carrying it out in darkness to prevent photo-
isomerization of RA. Cell viability was assessed by a negative reaction
with the “in situ cell death detection kit (AP)” (Boehringer Manheim).
Immunofluorescent staining for confocal microscopy was carried out
either on cytocentrifuge preparations or glass microscopic slides placed
into the culture vessels. Thin layer chromatography was used to detect
the formation of DALP (RF 0.6) from its methyl carbamate (RF 0.85)
after 48 h in Me2SO- and RA-treated cells using cell lysates and Kie-
selgel 60 silica plates (Merck, Darmstadt, Germany) in ethyl acetate:
pyridine:acetic acid:water (40:20:6:11) after precipitation of proteins
with 5% trichloroacetic acid.
Measurement of Transglutaminase Activity—Transglutaminase ac-
tivity in cell lysates was assayed by determining the incorporation of
[3H]putrescine (Amersham Corp., Bucks, UK) into dimethylcasein as
described previously (30). Results shown represent the mean of five
independent determinations.
Identification of Proteins by Western Blot Analysis—Samples were
diluted with an equal volume of 2 3 Laemmli sample buffer and boiled
for 5 min, then subjected to PAGE in the presence of SDS using 10%
slab gels and 4% stacking gel (31). Proteins were reduced with 100 mM
DTT, alkylated with 2% iodoacetamide, and were detected by staining
with Coomassie Brillant Blue R or after transfer onto Immobilon P
(Millipore Corp., Bedford, MA). Binding of primary rabbit anti-dinitro-
phenyl antibodies was visualized by alkaline phosphatase coupled
swine anti-rabbit antiserum (Dakopatts, Glostrup, Denmark) or, alter-
natively, with sheep anti-rabbit antibodies coupled to peroxidase (Da-
kopatts). Monoclonal anti-tissue TGase antibody (P. J. Birckbichler,
Oklahoma Medical Research Foundation, Oklahoma City, OK) was
detected with rabbit anti-mouse immunoglobulins coupled to alkaline
phosphatase. Monoclonal anti-actin antibodies (clone AC-40 and AC-15,
Sigma) were reacted with peroxidase-conjugated sheep anti-mouse IgG
(Sigma). Alkaline phosphatase-coupled antibodies were visualized us-
ing 5-bromo-4-chloro-3-indolyl phosphate and nitro blue tetrazolium as
chromogenic agents; peroxidase was detected by chemiluminescence
(Supersignal, Pierce). Stripping of antibodies from membranes for rep-
robing was done by incubating them in 2% SDS, 1% 2-mercaptoethanol
for 1 h at 55 °C.
Isolation of DALP-labeled Proteins from Cells—U937 cells treated for
72 h as above were collected and washed twice with centrifugation and
resuspending in cold buffer A (15 mM phosphate sodium, 1 mM EDTA,
pH 7.5, 140 mM NaCl) and then lysed by boiling in 2% SDS, 100 mM
DTT, 5 mM EDTA, 50 mM Tris, pH 8.0. Sulfhydryl groups were alky-
lated by incubation with 0.1 M iodoacetamide for 30 min at room
temperature. This protein solution was precipitated with cold acetone,
treated with 100% trifluoroacetic acid for 30 min on ice to hydrolyze
carbamate esters, lyophilized, and redissolved in 2% SDS, 125 mM
Tris-Cl, pH 6.8, and 0.01% bromphenol blue. Then, the sample was
applied on top of a 37 3 150-mm Bio-Rad PrepCell 491 preparative
SDS-PAGE column filled with 3% gel. Column eluate harboring eluted
proteins in 192 mM glycine, 25 mM Tris-HCl, pH 6.8, and 0.1% SDS was
led through a 0.5 3 5-cm column filled with rabbit anti-dinitrophenyl
immunoglobulins coupled hydrazide-linked beads. The latter was pre-
pared by Affi-Gel Hz immunoaffinity kit (Bio-Rad) according to the
protocol described by the supplier. In control experiments it was deter-
mined that neither DALP nor DALP-labeled proteins bind to either
uncoupled beads or those coupled with non-specific rabbit antibody, and
unlabeled cell homogenates were not immunoreactive with anti-dini-
trophenyl antibody under the conditions described. Sample electro-
phoresis and eluate affinity purification was carried out for 24 h, which
duration was determined to be more than double the passage time of
thyroglobulin (mass of 336 kDa). Affinity-bound proteins were released
from the beads by boiling in 2% SDS, 125 mM Tris, pH 6.8. This solution
was subjected to SDS-PAGE and then stained with Coomassie Brilliant
Blue R. In some experiments, the major lower bands running at 45 kDa
were collected and electro-eluted in 10 mM CAPS, pH 11, 0.1% SDS.
Separation and Sequencing of Peptides from Isolated Proteins—Elec-
tro-eluted proteins were precipitated with cold acetone and fragmented
FIG. 1. The structure of DALP, a novel transglutaminase sub-
strate, and its membrane-permeable methyl carbamate
derivative.
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by an equal weight of cyanogen bromide (Aldrich) in 70% formic acid
overnight at room temperature. Fragments were isolated on a Nova-
Pack C18 (Waters) reverse phase column using a linear gradient from
0 to 40% acetonitrile with 0.1% trifluoroacetic acid (solvent B) versus
0.1% trifluoroacetic acid in water (solvent A). Absorbance was detected
at 206 nm. Peptides giving major and solitary peaks were analyzed by
a Knauer 910 protein microsequencer (Herbert Knauer GmbH, Berlin,
Germany). Sequences were searched against the EMBO SwissProt data
base.
Immunofluorescent Staining and Confocal Image Microscopy—Cells
adhered or centrifuged to microscopic slides were fixed with St. Marie’s
fixative (2% acetic acid in ethanol) at 220 °C for 30 min and air-dried.
Nonspecific binding of antibodies was blocked with 5% nonfat milk
powder, 2% bovine serum albumin, 0.5% sheep serum at 37 °C in
Tris-buffered saline containing 0.1% Triton X-100 (TBS-Tx). After
washing in TBS-Tx actin microfilaments were visualized with phalloi-
din-TRITC (Sigma Chemical Co.) at 0.25 mg/ml concentration in the
presence of 1% bovine serum albumin in TBS-Tx. DALP was reacted
with rabbit serum containing anti-dinitrophenol antibodies and, con-
secutively, with biotinylated donkey anti-rabbit immunoglobulins (Am-
ersham), then with streptavidin-fluorescein isothiocyanate (Boehringer
Mannheim, Penzberg, Germany) at 10 mg/ml, all in TBS-Tx. Tissue
TGase was detected using the above described monoclonal antibody and
applying goat anti-mouse IgG-TRITC (Sigma) in the presence of
TBS-Tx and 1% bovine serum albumin. Immunofluorescent stainings
were analyzed using a confocal laser scanning invert microscope LSM
410 (Carl Zeiss, Oberkochen, Germany) equipped with external argon
ion (488/514 nm) and internal helium-neon (543 nm) lasers. Plan
Neoflutar 3100 objective was used. To visualize fluorescein isothiocya-
nate labeling, cells were exposed to laser excitation at 488 nm and
emission was detected through a filter BP 510–525 nm. TRITC was
excited at 543 nm and emission was detected through an LP 570 filter.
The laser beam was attenuated to 10% with a neutral filter to reduce
the bleaching of fluorescence. The image acquisition was performed
under the following conditions. (a) The pinhole unit in front of the
detector was opened and fitted to Airy Unit 1, (b) the average of four
images was recorded in 1 s and 512 3 512 pixels, (c) the optical section
thickness (z step) was approximately 0.5 mm, and (d) the scanning zoom
was varied between 1.5 and 3.5. Images were digitized and stored on
floppy disks.
RESULTS
Induction of Tissue Transglutaminase and Apoptosis in
HL-60 and U937 Cells by Me2SO and All-trans-retinoic Acid—
Synergistic effect of Me2SO and RA caused growth arrest and
massive cell death of both U937 and HL-60 cells. Features of
cellular morphology were consistent with the apoptotic process,
such as blebbing of cytoplasmic margins, nuclear shrinkage, or
karyorrhexis, in agreement with previous findings (23, 24).
Decrease of cell survival was maximal between 60 and 84 h of
treatment (Fig. 2). Remnants of dead cells were found to un-
dergo autolysis and swelling on prolonged incubation; thus, the
time of treatment was limited to 72 h. TGase activity of cell
homogenates surged from background values up to 7.4 nmol/
min/mg for HL60 and 15.6 nmol/min/mg mean activity values
for U937 cells by 48 h of induction and declined afterward in
correlation with decreasing cell viability (Fig. 2). Induction of
tissue TGase was demonstrated by immunoblotting (Fig. 2),
which revealed undetectable low levels of the antigen in un-
treated cultures. Cultures treated with RA alone did not show
expression of the enzyme, either, in agreement with previous
findings (21). Detergent-insoluble, cross-linked apoptotic bod-
ies could also be isolated, suggesting that tissue TGase is
activated and polymerizes proteins in the dying cells (2, 19, 32).
Synthesis of DALP, a Novel Transglutaminase Substrate,
and Its Incorporation into Cellular Proteins—In an attempt to
identify intracellular glutaminyl substrates of TGase, a novel
hapten-labeled amine substrate was designed. The compound
DALP (Fig. 1) was synthesized with an acceptable 26% yield in
a four-step reaction procedure. Substrate properties of DALP
have been verified by incorporating it into dimethylated casein
by tissue TGase and chromatographic identification of g-glu-
tamyl-DALP. The determined Km value of DALP (3 mM) is
about 50 times lower than the best amine substrate of TGase
found to date: (5-biotinamido)pentylamine (29). DALP concen-
trations below 1 mM were found to be non-toxic to HL-60 and
U937 cells. As it is the case with other amine substrates like
monodansylcadaverine (33) or biotin-cadaverine (25), the
DALP itself did not show applicable uptake by HL-60 or U937
cells. However, its carbamate methyl ester derivative was
found to penetrate both types of cells. This derivative, which
was not toxic in the applied concentration to the examined cells
FIG. 2. Induction of apoptosis (A) and tissue transglutaminase
(B) in HL-60 (1) and U937 cells (2) following the combined treat-
ment of Me2SO and all-trans-retinoic acid. Immunoblot analysis
(C) of tissue TGase shows the presence of the enzyme protein 72 h after
the addition of Me2SO and RA to the culture.
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and did not influence either their differentiation or the rate of
apoptosis, became hydrolyzed inside cells, as demonstrated by
thin layer chromatography of non-protein fraction of cells cul-
tured for 48 h in the presence of Me2SO and RA (data not
shown). In cells incubated in the presence of DALP-methyl
ester and treated with Me2SO and RA, the incorporation of
DALP into intracellular proteins was detectable after 72 h with
immunoblot analysis using anti-dinitrophenyl antibodies (Fig.
3). The covalent incorporation of DALP into cellular proteins
was a specific result of cellular Tgase activity as the formation
of DALP derivatives have not been observed unless tissue
TGase and apoptosis were induced by the combined treatment
of Me2SO and retinoic acid and the incorporated DALP could be
recovered as g-glutamyl-DALP from proteolytic digests of cel-
lular proteins (data not shown). Intracellular DALP labeling of
living cells revealed transglutamination of very few cellular
proteins contrasted to nonspecific transglutaminase-mediated
labeling of cell lysates resulting in a continuous spread of
labeled proteins on Western blots (data not shown).
The most intensively labeled protein in apoptotic cells had a
molecular mass of 43 kDa. Further bands were seen at the
approximate position of 110 and 150 kDa. In addition, high
molecular mass materials retarded at the top of the resolving
gel (.250 kDa), as well as the stacking gel (.1 MDa) have been
observed. The amount of these high molecular mass protein
masses is presumably even more than the figure suggests, as
proteins of these sizes are transferred to the membranes with
poor efficiency. The pattern of protein labeling was the same in
case of both cell lines (Fig. 3), although HL-60 showed conse-
quently weaker labeling intensity. This is in agreement with
the weaker and more limited induction of nonspecific esterase
in these cells (25) as compared with U937 cells (34).
Isolation and Identification of the Major TGase Sub-
strate—By labeling U937 cells with DALP in bulk quantities,
endogenous substrate proteins of tissue TGase could be iso-
lated from the total mass of cellular proteins applying a care-
fully chosen procedure detailed under “Experimental Proce-
dures.” After the non-incorporated label was removed by
precipitation and electrophoretic techniques, the proteins bear-
ing the haptenic group were isolated by an immunoaffinity
column utilizing the phenomenon that the interaction between
the applied antibodies and the labeled proteins was not affected
by 0.1% SDS at room temperature. Immunoblot analysis of the
isolated proteins gave a labeling pattern very similar to that of
the crude cell homogenate (Fig. 4). The majority of the labeled
proteins was in the 43-kDa band. The additional two upper
bands of the immunoblot were at least 1 order of magnitude
less in relative quantity. A direct N-terminal sequencing of the
labeled proteins was not possible because of N-terminal block-
age. The 43-kDa protein was then isolated by electroblotting
following PAGE and fragmented with CNBr. Peptide frag-
ments were separated by reverse-phase HPLC chromatography
(Fig. 4), and amino acid sequences of the isolated peptides were
analyzed by microsequencing. The obtained sequences were
searched against the Swiss-Prot protein sequence data base for
identical sequences. In the case of each read sequence, only
actins gave full matching in the search and only non-muscle
(cytoplasmic) actins contained all the identified sequences (Ta-
ble I). The identity of the isolated protein with cytoplasmic
actin was further confirmed using monoclonal anti-actin anti-
bodies (Fig. 5); the 43-kDa band of the hapten-labeled proteins
reacted with both anti-dinitrophenol and anti-actin antibodies.
Actin immunoreactivity was also seen with the unresolved high
molecular mass proteins, suggesting that actin is an ingredient
of the cross-linked protein polymer formed by tissue TGase in
the dying cells. The two labeled proteins of approximate mo-
lecular masses of 110 and 150 kDawere not recognized by the
anti-actin antibodies. These proteins were identified as retino-
blastoma protein derivatives by specific antibodies; these re-
sults will be discussed in conjunction with a separate set of
data (35).
Subcellular Localization of the Incorporated Label and Tis-
sue Transglutaminase—U937 cells induced to differentiate by
Me2SO and RA in the presence of DALP-methyl carbamate
were cytocentrifuged or adhered to glass slides. Following fix-
ation and washing (to remove non-incorporated DALP), the
number of cells undergoing apoptosis was determined and the
subcellular localization of TGase and incorporated DALP was
visualized by immunofluorescence and investigated by confocal
image microscopy. DALP fluorescence was not detectable in
cells obtained in the early phase of the culture (before 60–72 h)
or in those not treated with Me2SO and RA. It was observed in
triplicate experiments with double fluorescence staining for
TGase and DALP, or DALP and apoptotic nuclear fragmenta-
tion, or apoptosis and TGase (Table II) that at 72 h of treat-
ment, i) DALP incorporation occurred in a large number of cells
and only those containing TGase, ii) the majority of apoptotic
FIG. 3. Detection of DALP-labeled proteins in cell lysates. A,
Western blot analysis of DALP-labeled proteins from HL-60 (1 and 3)
and U937 (2 and 4) cells to detect the dinitrophenol haptenic group.
DALP-labeled proteins could not be found in cells not treated with
Me2SO and RA (1 and 2). B, analysis of DALP-labeled proteins by PAGE
and Coomassie staining (1) and by Western blotting using anti-dinitro-
phenol antibody (2) from U937 cells following their purification by
affinity chromatography utilizing anti-dinitrophenol antibodies.
FIG. 4. Separation of CNBr peptides from the 43-kDa DALP-
labeled and affinity-purified protein from U937 cells by reverse
phase HPLC.
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cells had DALP labeling, and iii) almost all apoptotic cells
expressed TGase. Since the difference between neither of the
aforesaid three double positive population was significant (Ta-
ble II), one may conclude that most of the double positive cells
must necessarily be positive for all the three parameters, i.e.
apoptosis, transglutaminase expression, and covalent cross-
linking of cellular proteins very much coincide.
The pattern of DALP labeling revealed a distinct and mainly
filamentous distribution by confocal slicing (Fig. 6A), whereas
the distribution of cytoplasmic actin did not resolve any sort of
structure (data not shown), since it is mainly monomer G actin
that is detected by monoclonal anti-actin antibodies. On the
other hand, by staining with phalloidin-TRITC, which reacts
only with fibrillary actin, the stress fibers of adherent cells
could be selectively stained and this staining gave a very close
overlap with the pattern of DALP staining (Fig. 6, A–C). It is
noteworthy that the incorporation pattern of DALP was
mostly, but not entirely, restricted to the actin cytoskeleton
(Fig. 6C, green color). The distribution of tissue TGase was
diffuse throughout the cytoplasm and did not co-localize with
the incorporated label (Fig. 6, C–E). Disrupted cells showing
either necrotic or late apoptotic features lost their arranged
stress fibers, and the staining pattern was diffuse similarly to
that of non-adherent cells (data not shown).
DISCUSSION
Tissue transglutaminase is often highly expressed at sites of
programmed cell death (17–19, 32), and its induction has been
observed in association with apoptosis of several cultured cell
lines (23, 32, 36). However, defining the precise role of this
enzyme in the cell death pathway requires the identification of
its substrates cross-linked in the dying cells. Apart from nu-
merous abundant extracellular proteins, several intracellular
substrates have been shown to be in vitro TGase substrates
including b-crystallins (37), lipocortin (38), fructose-1,6-
bisphosphate aldolase (14), and actin itself (39). Although the
variety of putative enzyme substrates would make it necessary
to determine whether the substrate properties of particular
proteins really have physiological significance or not, these
results either were obtained in test tube experiments or were
greatly compromised by the insufficient permeability of the
applied amine substrates because of the strong dissociation of
the amino groups at physiologic pH values and the potential
barrier of cytoplasmic membrane for ionic charge. In our ap-
proach, the charge barrier could be overcome by the use of the
methyl carbamate derivative of the amine substrate DALP,
which is hydrolyzed by esterases inside cells and then specifi-
cally incorporated into cellular proteins.
HL-60 and U937 cells differentiate upon treatment with
Me2SO and retinoic acid. Maturated phenotypes express high
levels of tissue transglutaminase and die by apoptosis. DALP
labeling of TGase substrates and studying the main labeled
protein by DALP-specific purification and microsequencing
identified cytoplasmic actin as one of the major targets of the
enzyme in cells. Subcellular distribution of the incorporated
molecules showed a strongly overlapping pattern with actin
microfilaments. Actin was found to be a substrate for tissue
transglutaminase in test tube experiments, both in its globular
and polymeric form (39), and our present results clearly dem-
onstrate that actin serves as the major substrate of tissue
TGase in dying cells. The lack of DALP labeling of other abun-
dant proteins of the cellular machinery (such as tubulin) also
points to the specificity of actin labeling. It was also demon-
strated that Gln-41 is the main amine acceptor site for the
transglutaminase reaction (39, 40), and the enzyme can also
form trace amounts of covalently cross-linked actin oligomers
from G actin, which may act as “seeds” to allow actin to polym-
erize faster. Furthermore, since Gln-41 is accessible in F actin
as well (39) and according to our present results the high
molecular weight polymers formed by TGase are also labeled by
DALP, it is very likely that additional proteins are attached
covalently, through their accessible Lys residues, to the micro-
fibrillar meshwork by the enzyme. Actin from human blood
platelets or rabbit skeletal muscle has also been shown to serve
as substrate for factor XIIIa (41), a transglutaminase that is
different in both structure and reactivity toward glutamine
containing peptide substrates (2, 3). The highly cross-linked
matrix of platelets formed by the transglutaminase reaction
also contains actin (42).
Changes of microfibrillar architecture have been proposed to
determine the morphological events of apoptosis (5). Hallmarks
of apoptosis like cytoplasmic blebbing and fragmentation of the
nucleus can be inhibited by cytochalasin leading to disruption
of actin filaments (43, 44). Cells unable to maintain their
proper shape and cytoskeletal arrangement because of the loss
of contact with the extracellular matrix die by apoptosis (45,
46). On the other hand, apoptosis results in increasing disrup-
tion of actin fibers in certain cells (47). The process of apoptosis
may be regulated by proteolytic processing of actin or by other
components of the microfilament system (48–51). The modifi-
cation of actins and their filaments by the transglutaminase-
dependent cross-linking reaction is another possible way of
regulating actin-dependent morphologic and biochemical
events of apoptosis and thereby executing cell death. Under the
conditions of our experiments, it is not possible to decide what
switches on the activity of the enzyme and when. Our data
suggest that transglutaminase activation is a late event of
apoptosis, since the covalent incorporation of DALP into actin
filaments occurs in a significant amount after about 60 h fol-
lowing treatment with Me2SO and retinoic acid, i.e. when most
cells showed molecular signs of apoptosis as assessed by the
detection of DNA breaks in the nucleus. It should be noted that
FIG. 5. Western blot analysis of the affinity-isolated endoge-
nous TGase substrate proteins from U937 cells with anti-DNP
and anti-actin antibodies visualizing reactive bands with the
chemiluminescence reaction.
TABLE I
Identification of CNBr peptides obtained from the purified 43-kDa
DALP-labeled protein by matching their sequences to known protein
sequences of human origin
Peptide Sequence read Identical sequence found in:
P6 MXXEITALAPS Actin, muscle, and cytoplasmic isoforms
P10 MXXTFNP Actin, muscle, and cytoplasmic isoforms
P15 MXKAGFAGDD Actin, cytoplasmic isoforms
P20 MXIKIIAPPER Actin, muscle, and cytoplasmic isoforms
P23 MATAASSSSL Actin, muscle, and cytoplasmic isoforms
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these cells are not permeable to vital stains such as trypan
blue.
Apoptosis, in contrast to necrosis, is a “silent” form of cell
death without the release of aggressive enzymes, hidden anti-
gens, or agents inducing inflammation (52). Even if the execu-
tion of the apoptotic process does not need novel gene expres-
sion (53), the events of this program are more ordered than
necrosis in terms of both morphology and biochemistry. Order,
among others, means maintained compartmentalization and
restricted movements of subcellular organelles in which a cru-
cial role of statics and dynamics of the cytoskeletal can be
assumed. It may be hypothesized that cross-linking of various
TABLE II
Immunofluorescent staining of U937 cells for the presence of TGase, DALP incorporation, and nuclear fragmentation 72 h following RA and
Me2SO treatment
Table shows results (mean 6 S.E.) of triplicate experiments counting at least 100 cells in each case.
Staining
Immunopositive cells (%)
By 1st stain By both stains Double positives as % of 1st stainpositives/2nd stain positives
TGase (1st stain) 1 DALP (2nd stain) 78.5 6 1.94 75.2 6 3.85a 95.8/100
DALP (1st stain) 1 NF (2nd stain) 75.4 6 3.63 74.2 6 2.54a 98.4/91.8
NF (1st stain) 1 TGase (2nd stain) 80.8 6 3.74 74.0 6 2.82a 92.6/94.2
a The difference between neither of these populations is significant by Student’s test (0.8 , p , 0.9 for all three cases).
FIG. 6. Confocal immunofluores-
cent images showing intracellular
distribution of DALP-labeled TGase
substrate proteins (A and D), actin
microfilaments (B), tissue TGase (E),
and superimposed images of A and B
(C) or D and E (F) of U937 cells. On
superimposed images co-localization ap-
pears in yellow, whereas the red or green
color indicates non-overlapping reactions.
Intracellular distribution of DALP incor-
poration corresponds to actin labeling by
phalloidin-TRITC (compare A and B to C)
but not to the localization of tissue TGase
(compare D and E to F). Bar 5 10 mm.
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intracellular proteins to actin is involved in such processes
stabilizing cellular morphology, counteracting the release of
cytoplasmic material from cells (19), and exerting a morpho-
genic role in programmed cell death (54).
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